First Ruida Medical-B (06669.HK) announced that on January 17 this year, the State Drug Administration accepted its application for registration of AcoArt Orchid&Dhalia for the treatment of arteriovenous stenosis (AVF).
AVF is an artificially opened channel between arteries and veins for hemodialysis in patients with end-stage renal disease (ESRD). However, due to periodic trauma and hemodynamic changes, the vessel is easy to cause stenosis, and DCB can effectively treat the stenosis.